How copper explorer Kincora ups its odds
The hardest part of the junior exploration game is funding. But Kincora Copper is showing how to multiply the cash you have to play with.
Stockhead
Electric cars drive novated leasing take-up
Despite the discontinuance of the FBT exemption on petrol-electric vehicles, EVs will remain a popular choice for novated leases.
ASX lifts on strength in gold, oil and rare earths
Despite heavy damage to US markets overnight, the ASX has made solid gains today, posting a 0.64pc lift on strength in oil, gold and rare earth stocks.
ASX up and gold hits record despite Powell’s warning
Gold has hit another record, sending the ASX up. Powell’s rate cut warning slammed Wall Street overnight but BHP and Santos have rallied.
More Stories
Zijin takes stake in Strickland
Strickland Metals shone on the last day of a short week after securing a $5m placement to global gold player China’s Zijin Mining at market.
Lumos soars on US wins for FebriDx test
Lumos Diagnostics jumps 18% on US reimbursement wins for FebriDx, its rapid test that distinguishes bacterial vs non-bacterial respiratory infections.
3 buying opportunities on the ASX right now
Markets might be rocky but there are still good opportunities worth looking at, according to VP Capital’s John So.
Gold’s path to US$4000/oz
Could gold run as high as US$4000/oz? This fundie who picked the gold bull run early thinks conditions are there to fire bullion further.
Aussie biotechs are tipped to avoid the worst of the tariff fallout
A report from Bell Potter shows that while US-facing biotechs should be on high alert, the likely impact of tariffs is manageable.
ASX lifts on rising oil prices
The ASX is higher in the first hour of trading on the back of strengthening oil prices, despite falls across the board in US markets overnight.
IMR wins Euro assent for world-leading heart tool
Imricor receives CE Mark certification for the Advantage-MR system under new European Medical Device Regulation as it hits world first with start of VISABL-VT trial.
Neurizon strengthens team for commercial push
Clinical stage neurodegenerative biotech Neurizon has strengthened its executive team as part of commercialisation efforts.
Original URL: https://www.couriermail.com.au/business/stockhead